Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07046845 · ClinicalTrials.gov registry record · NA

Perelel Prenatal Supplements vs. Generic Prenatal Supplements and Health of Mother and Baby (SUPPORT)

A NA study of Pregnancy, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
600
Enrollment target
1
Study location

NCT07046845: Recruiting NA study of Pregnancy, sponsored by University of Pittsburgh.

NCT07046845 is a NA study of Pregnancy that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 600 participants, below the 870-participant average among 191 other Pregnancy trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07046845, a NA study of Pregnancy, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn if using Perelel-brand prenatal supplements versus a generic prenatal supplement improves the health of the mother and fetus (unborn baby) during pregnancy. The main question it aims to answer is: • How does taking Perelel prenatal supplements versus generic prenatal supplements during pregnancy change the nutritional markers in blood samples? Participants will: * Take either Perelel or generic prenatal supplements daily throughout pregnancy * Visit UPMC Magee-Womens Hospital once every trimester of pregnancy for blood draws and answering questionnaires In an observational part of this study for different participants, researchers will use blood tests and questionnaires only once during the first trimester to compare pregnant women without food insecurity to those with food insecurity.

Primary Outcome

Assay of Serum 25-hydroxyvitamin D3 in Blood Samples

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Perelel Prenatal Vitamin
  • DIETARY_SUPPLEMENT Generic Prenatal Vitamin

Study Locations (1)

Pennsylvania

  • UPMC Magee-Womens Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2026-01-07
Est. Completion 2027-06
Phase NA
University of Pittsburgh

1,238 total trials

What NCT07046845 shows while recruiting

NCT07046845 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 870-participant average among 191 other Pregnancy trials with a reported enrollment target (31% lower).

The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Perelel Prenatal Vitamin is the first listed.

NCT07046845 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07046845 about?

NCT07046845 is a clinical study titled "Perelel Prenatal Supplements vs. Generic Prenatal Supplements and Health of Mother and Baby (SUPPORT)". The goal of this clinical trial is to learn if using Perelel-brand prenatal supplements versus a generic prenatal supplement improves the health of the mother and fetus (unborn baby) during pregnancy. The main question it aims to answer is: • How does taking Perelel prenatal supplements versus gen...

What is the current status of trial NCT07046845?

This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2026-01-07. Estimated completion is 2027-06.

What conditions does trial NCT07046845 study?

This clinical trial studies the following conditions: Pregnancy.

What interventions are being tested in trial NCT07046845?

The interventions under investigation include: Perelel Prenatal Vitamin (DIETARY_SUPPLEMENT), Generic Prenatal Vitamin (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07046845?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07046845 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07046845's enrollment target sits among peer trials

600 37th of 191 higher than 153 of 191 other Pregnancy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07046845, the US trial registry maintained by the National Library of Medicine. NCT07046845 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.